Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy

被引:0
|
作者
Eleonora Del Prete
Pierpaolo Turcano
Elisa Unti
Giovanni Palermo
Cristina Pagni
Daniela Frosini
Ubaldo Bonuccelli
Roberto Ceravolo
机构
[1] University of Pisa,Department of Clinical and Experimental Medicine, Neurology Unit
[2] Mayo Clinic,Mayo Clinic Department of Neurology
[3] AOUP,Department of Medical, Specialities Neurology Unit
来源
Neurological Sciences | 2020年 / 41卷
关键词
Theory of mind; Parkinson’s disease; Dopaminergic therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Theory of mind (ToM) is the ability to attribute mental states to one self and others and to understand that others have beliefs different from one’s own. Different subcomponents of ToM have also been identified: cognitive and affective. Cognitive ToM refers to the capacity to infer others’ beliefs and intentions, while affective ToM implies the ability to appreciate others’ emotional states. The aim of this study was to explore ToM in drug-naïve Parkinson’s disease (PD) patients and to investigate the effects of chronic dopaminergic therapy on different subcomponents of ToM during a 3 months and 1 year of follow-up. We examined 16 PD patients in three conditions: before (un-medicated) and after dopaminergic therapy (medicated 3 months: T1 and medicated 1 year: T2). We also compared our PD’s ToM abilities with 11 healthy individuals. ToM was explored with 5 different tasks: Faux Pas Test, Picture Sequencing Task Capture Story, Emotion Attribution Task, Strange Stories Task, and Karolinska Directed Emotional Faces. Our study confirms that PD patients present deficits in cognitive components of ToM and preserved performances in the affective ones in early stages of disease. We also find a significant effect of dopaminergic therapy on ToM already after 3 months with a good persistency after 1 year of treatment.
引用
收藏
页码:2761 / 2766
页数:5
相关论文
共 50 条
  • [1] Theory of mind in Parkinson's disease: evidences in drug-naive patients and longitudinal effects of dopaminergic therapy
    Del Prete, Eleonora
    Turcano, Pierpaolo
    Unti, Elisa
    Palermo, Giovanni
    Pagni, Cristina
    Frosini, Daniela
    Bonuccelli, Ubaldo
    Ceravolo, Roberto
    NEUROLOGICAL SCIENCES, 2020, 41 (10) : 2761 - 2766
  • [2] Putamen dopaminergic dysfunction is associated with sleep disturbance in drug-naïve patients with Parkinson's disease
    Ozawa, Masakazu
    Murakami, Hidetomo
    Muraoka, Yuichiro
    Ibukuro, Momoyo
    Shiraishi, Tomotaka
    Onda, Asako
    Matsuno, Hiromasa
    Bono, Keiko
    Umehara, Tadashi
    Omoto, Shusaku
    Okano, Hirotaka James
    Iguchi, Yasuyuki
    SLEEP MEDICINE, 2025, 129 : 82 - 88
  • [3] Blood transcriptomics of drug-naïve sporadic Parkinson’s disease patients
    Raffaella Calligaris
    Mihaela Banica
    Paola Roncaglia
    Elisa Robotti
    Sara Finaurini
    Christina Vlachouli
    Lucia Antonutti
    Francesco Iorio
    Annamaria Carissimo
    Tatiana Cattaruzza
    Andrea Ceiner
    Dejan Lazarevic
    Alberto Cucca
    Nicola Pangher
    Emilio Marengo
    Diego di Bernardo
    Gilberto Pizzolato
    Stefano Gustincich
    BMC Genomics, 16
  • [4] Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
    Yang Hyun Lee
    Jungho Cha
    Seok Jong Chung
    Han Soo Yoo
    Young H. Sohn
    Byoung Seok Ye
    Phil Hyu Lee
    Scientific Reports, 9
  • [5] Serum phosphorus levels associated with nigrostriatal dopaminergic deficits in drug-naïve Parkinson's disease
    Umehara, Tadashi
    Mimori, Masahiro
    Kokubu, Tatsushi
    Ozawa, Masakazu
    Shiraishi, Tomotaka
    Sato, Takeo
    Onda, Asako
    Matsuno, Hiromasa
    Omoto, Shusaku
    Murakami, Hidetomo
    Oka, Hisayoshi
    Iguchi, Yasuyuki
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 464
  • [6] Obsessive–compulsive personality disorder in drug-naïve Parkinson’s disease patients
    Alessandra Nicoletti
    Antonina Luca
    Maria Luca
    Giovanni Mostile
    Giorgia Sciacca
    Antonino Petralia
    Mario Zappia
    Journal of Neurology, 2015, 262 : 485 - 486
  • [7] Apathy in drug-na⟨ve patients with incident Parkinson's disease: the Norwegian ParkWest study
    Pedersen, Kenn Freddy
    Alves, Guido
    Bronnick, Kolbjorn
    Aarsland, Dag
    Tysnes, Ole-Bjorn
    Larsen, Jan Petter
    JOURNAL OF NEUROLOGY, 2010, 257 (02) : 217 - 223
  • [8] The Natural Progression of Parkinson’s Disease in a Small Cohort with 15 Drug-na?ve Patients
    Liu Ying
    Fan Jin-Hu
    Gao Xiang
    Ma Li
    Qiao You-Lin
    Zhang Lin
    中华医学杂志英文版, 2015, 128 (13) : 1761 - 1764
  • [9] A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study
    Jacopo Troisi
    Annamaria Landolfi
    Carmine Vitale
    Katia Longo
    Autilia Cozzolino
    Massimo Squillante
    Maria Cristina Savanelli
    Paolo Barone
    Marianna Amboni
    Metabolomics, 2019, 15
  • [10] Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
    Wiebke Grashorn
    Odette Fründt
    Carsten Buhmann
    Nathalie Wrobel
    Katharina Schmidt
    Ulrike Bingel
    Neurological Research and Practice, 1